Selinexor: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

25 October 2024

  • curprev 21:3921:39, 25 October 2024‎ Omid Afkhami-Ardakani talk contribs‎ m 3,836 bytes +21‎ No edit summary Tag: Visual edit
  • curprev 21:3221:32, 25 October 2024‎ Omid Afkhami-Ardakani talk contribs‎ 3,815 bytes +3,815‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Omid Afkhami Ardakani |genericName=Selinexor |aOrAn=a |drugClass=Selective Inhibitor of Nuclear Export (SINE) |indicationType=treatment |indication=Relapsed or Refractory Multiple Myeloma (RRMM), Diffuse Large B-Cell Lymphoma (DLBCL) |hasBlackBoxWarning=Yes |adverseReactions=Nausea, fatigue, decreased appetite, diarrhea, peripheral neuropathy, upper respiratory tract infection, weight loss |blackBoxWarningTitle=Serious Hematologic a..."
Retrieved from "https://www.wikidoc.org/index.php/Selinexor"